arrow
S

Shrilla Banerjee

Maasstad Hospital
H指数:13
被引数:673

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Intravascular lithotripsy for calcified coronary lesions: contemporary trends and long-term outcomes in acute myocardial infarction patients - insights from the CLEAR registry

血管内冲击波碎石术治疗钙化冠状动脉病变:急性心肌梗死患者的当代趋势和长期结局——来自CLEAR注册研究的数据

2026-01-010
PRE
DEUCRAVACITINIB, A FIRST-IN-CLASS, ORAL, SELECTIVE, ALLOSTERICTYROSINE KINASE 2 (TYK2) INHIBITOR, IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): EFFICACY BY BASELINE DEMOGRAPHICS AND DISEASE CHARACTERISTICS IN THE PHASE 2 PAISLEY TRIAL

DEUCRAVACITINIB,一种首创的、口服的、选择性的、变构酪氨酸激酶2(TYK2)抑制剂,在系统性红斑狼疮(SLE)中的疗效:基于PAISLEY二期试验基线人口统计学和疾病特征的疗效分析

2024-06-010
PRE
Ethnic disparities in care and outcomes of non-ST-segment elevation myocardial infarction: a nationwide cohort study

非ST段抬高型心肌梗死的治疗和预后的种族差异: 一项全国性队列研究

2021-04-2132
OAAI